Heart Failure and Chronic Kidney Disease Patients
- 19 July 2021
- journal article
- editorial
- Published by Elsevier BV in Journal of Invasive Cardiology
- Vol. 78 (4), 344-347
- https://doi.org/10.1016/j.jacc.2021.05.027
Abstract
No abstract availableThis publication has 13 references indexed in Scilit:
- Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 DiabetesThe New England Journal of Medicine, 2020
- Unravelling the interplay between hyperkalaemia, renin–angiotensin–aldosterone inhibitor use and clinical outcomes. Data from 9222 chronic heart failure patients of the ESC‐HFA‐EORP Heart Failure Long‐Term RegistryEuropean Journal of Heart Failure, 2020
- Emerging Drug Classes and Their Potential Use in HypertensionHypertension, 2019
- Prescription of renin‐angiotensin‐aldosterone system inhibitors (RAASi) and its determinants in patients with advanced CKD under nephrologist careThe Journal of Clinical Hypertension, 2019
- Trends in Angiotensin-Converting Enzyme Inhibitor and Angiotensin II Receptor Blocker Use among Those with Impaired Kidney Function in the United StatesJournal of the American Society of Nephrology, 2019
- Heart failure drug treatmentThe Lancet, 2019
- Angiotensin–Neprilysin Inhibition in Acute Decompensated Heart FailureThe New England Journal of Medicine, 2019
- Cardiorenal Syndrome RevisitedJournal of the American College of Cardiology, 2018
- A real-world cohort study on the quality of potassium and creatinine monitoring during initiation of mineralocorticoid receptor antagonists in patients with heart failureEuropean Heart Journal - Quality of Care & Clinical Outcomes, 2018
- Consistency of Laboratory Monitoring During Initiation of Mineralocorticoid Receptor Antagonist Therapy in Patients With Heart FailureJAMA, 2015